Commentary on Myers et al.: Growing role of the innate immunity receptor CD36 in central nervous system diseases

Experimental Neurology

Volumn 261, Issue , 2014, Pages 633-637

  Garcia Bonilla, Lidia ^a   Park, Laibaik ^a   Iadecola, Costantino ^a  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; VAV PROTEIN; VERY LATE ACTIVATION ANTIGEN 6; AMYLOID BETA PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; BINDING SITE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN MALARIA; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SPINAL CORD INJURY; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; AMYLOID PLAQUE; BRAIN HEMATOMA; ENDOPLASMIC RETICULUM STRESS; MACROPHAGE; MICROGLIA; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; WHITE MATTER INJURY;

ANIMALS; ANTIGENS, CD36; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION;

EID: 84906852623     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.08.016     Document Type: Note

References (60)

1. Abe T., Shimamura M., Jackman K., Kurinami H., Anrather J., Zhou P., Iadecola C. Key role of CD36 in toll-like receptor 2 signaling in cerebral ischemia. Stroke 2010, 41:898-904.
2. Abumrad N.A., el-Maghrabi M.R., Amri E.Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 1993, 268:17665-17668.
3. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998, 188:1359-1368.
4. Amor S., Woodroofe M.N. Innate and adaptive immune responses in neurodegeneration and repair. Immunology 2014, 141:287-291.
5. Asch A.S., Barnwell J., Silverstein R.L., Nachman R.L. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 1987, 79:1054-1061.
6. Ballesteros I., Cuartero M.I., Pradillo J.M., de la Parra J., Pérez-Ruiz A., Corbí A., Ricote M., Hamilton J.A., Sobrado M., Vivancos J., Nombela F., Lizasoain I., Moro M.A. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways. J. Leukoc. Biol. 2014, 95:587-598.
7. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 2003, 23:2665-2674.
8. Bao Y., Qin L., Kim E., Bhosle S., Guo H., Febbraio M., Haskew-Layton R.E., Ratan R., Cho S. CD36 is involved in astrocyte activation and astroglial scar formation. J. Cereb. Blood Flow Metab. 2012, 8:1567-1577.
9. Barnwell J.W., Asch A.S., Nachman R.L., Yamaya M., Aikawa M., Ingravallo P. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J. Clin. Invest. 1989, 84:765-772.
10. Bin Wu., Ueno M., Kusaka T., Miki T., Nagai Y., Nakagawa T., Kanenishi K., Hosomi N., Sakamoto H. CD36 expression in the brains of SAMP8. Arch. Gerontol. Geriatr. 2012, 56:75-79.
11. Canton J., Neculai D., Grinstein S. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 2013, 13:621-634.
12. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 2001, 7:48-52.
13. Cho S., Kim E. CD36: a multi-modal target for acute stroke therapy. J. Neurochem. 2009, 109:126-132.
14. Cho S., Park E.M., Febbraio M., Anrather J., Park L., Racchumi G., Silverstein R.L., Iadecola C. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 2005, 25:2504-2512.
15. Collotteixeira S., Martin J., McDermott-Roe C., Poston R., McGregor J. CD36 and macrophages in atherosclerosis. Cardiovasc. Res. 2007, 75:468-477.
16. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., Luster A.D., Silverstein S.C., El-Khoury J.B. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 2002, 160:101-112.
17. Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., Bouck N.P. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 1997, 138:707-717.
18. El Khoury J.B., Moore K.J., Means T.K., Leung J., Terada K., Toft M., Freeman M.W., Luster A.D. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 2003, 197:1657-1666.
19. Fang H., Chen J., Lin S., Wang P., Wang Y., Xiong X., Yang Q. CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling. J. Immunol. 2014, 192:5984-5992.
20. Faraci F.M. Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1566-H1582.
21. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105:1049-1056.
22. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 2001, 108:785-791.
23. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zähringer U., Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
24. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866.
25. Isoviita P.M., Nuotio K., Saksi J., Turunen R., Ijäs P., Pitkäniemi J., Soinne L., Kaste M., Kovanen P.T., Lindsberg P.J. An imbalance between CD36 and ABCA1 protein expression favors lipid accumulation in stroke-prone ulcerated carotid plaques. Stroke 2010, 41:389-393.
26. Janabi M., Yamashita S., Hirano K., Sakai N., Hiraoka H., Matsumoto K., Zhang Z., Nozaki S., Matsuzawa Y. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1953-1960.
27. Jiménez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 2000, 6:41-48.
28. Jiménez B., Volpert O.V., Reiher F., Chang L., Muñoz A., Karin M., Bouck N. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene 2001, 20:3443-3448.
29. Kim E., Tolhurst A.T., Qin L.Y., Chen X.Y., Febbraio M., Cho S. CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury. J. Neurosci. 2008, 28:4661-4670.
30. Kim E., Febbraio M., Bao Y., Tolhurst A.T., Epstein J.M., Cho S. CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann. Neurol. 2012, 71:753-764.
31. Kouadir M., Yang L., Tan R., Shi F., Lu Y., Zhang S., Yin X., Zhou X., Zhao D. CD36 participates in PrP(106-126)-induced activation of microglia. PLoS ONE 2012, 7:e30756.
32. Kunz A., Abe T., Hochrainer K., Shimamura M., Anrather J., Racchumi G., Zhou P., Iadecola C. Nuclear factor-B activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J. Neurosci. 2008, 28:1649-1658.
33. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
34. Lampron A., Elali A., Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and its environment. Neuron 2013, 78:214-232.
35. McGilvray I.D., Serghides L., Kapus A., Rotstein O.D., Kain K.C. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood 2000, 96:3231-3240.
36. McGregor J.L., Catimel B., Parmentier S., Clezardin P., Dechavanne M., Leung L.L. Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J. Biol. Chem. 1989, 264:501-506.
37. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., Freeman M.W. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 2002, 277:47373-47379.
38. Myers S.A., Andres K.R., Hagg T., Whittemore S.R. CD36 deletion improves recovery from spinal cord injury. Exp. Neurol. 2014, 256:25-38.
39. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240.
40. Ockenhouse C.F., Tandon N.N., Magowan C., Jamieson G.A., Chulay J.D. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 1989, 243:1469-1471.
41. Oquendo P., Hundt E., Lawler J., Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989, 58:95-101.
42. Park Y.M. CD36, a scavenger receptor implicated in atherosclerosis. Exp. Mol. Med. 2014, 46:e99.
43. Park L., Wang G., Zhou P., Zhou J., Pitstick R., Previti M.L., Younkin L., Younkin S.G., Van Nostrand W.E., Cho S., Anrather J., Carlson G.A., Iadecola C. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5063-5068.
44. Park L., Zhou J., Zhou P., Pistick R., El Jamal S., Younkin L., Pierce J., Arreguin A., Anrather J., Younkin S.G., Carlson G.A., McEwen B.S., Iadecola C. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3089-3094.
45. Pongponratn E., Turner G.D.H., Day N.P.J., Phu N.H., Simpson J.A., Stepniewska K., Mai N.T.H., Viriyavejakul P., Looareesuwan S., Hien T.T., Ferguson D.J.P., White N.J. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2003, 69:345-359.
46. Prabhudas M., Bowdish D., Drickamer K., Febbraio M., Herz J., Kobzik L., Krieger M., Loike J., Means T.K., Moestrup S.K., Post S., Sawamura T., Silverstein S., Wang X.-Y., El Khoury J. Standardizing scavenger receptor nomenclature. J. Immunol. 2014, 192:1997-2006.
47. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006, 4:211-221.
48. Rahaman S.O., Swat W., Febbraio M., Silverstein R.L. Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation. J. Biol. Chem. 2011, 286:7010-7017.
49. Ransohoff R.M., Brown M.A. Innate immunity in the central nervous system. J. Clin. Invest. 2012, 122:1164-1171.
50. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 1995, 181:1857-1862.
51. Sheedy F.J., Grebe A., Rayner K.J., Kalantari P., Ramkhelawon B., Carpenter S.B., Becker C.E., Ediriweera H.N., Mullick A.E., Golenbock D.T., Stuart L.M., Latz E., Fitzgerald K.A., Moore K.J. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 2013, 14:812-820.
52. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2009, 2:re3-re3.
53. Smith T.G., Serghides L., Patel S.N., Febbraio M., Silverstein R.L., Kain K.C. CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect. Immun. 2003, 71:393-400.
54. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., El Khoury J., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2009, 11:155-161.
55. Su X., Maguire-Zeiss K.A., Giuliano R., Prifti L., Venkatesh K., Federoff H.J. Synuclein activates microglia in a model of Parkinson's disease. Neurobiol. Aging 2008, 29:1690-1701.
56. Ueno M., Nakagawa T., Nagai Y., Nishi N., Kusaka T., Kanenishi K., Onodera M., Hosomi N., Huang C., Yokomise H., Tomimoto H., Sakamoto H. The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Neuropathol. Appl. Neurobiol. 2011, 37:727-737.
57. Wilkinson B., Koenigsknecht-Talboo J., Grommes C., Lee C.Y.D., Landreth G. Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J. Biol. Chem. 2006, 281:20842-20850.
58. Woo M.-S., Wang X., Faustino J.V., Derugin N., Wendland M.F., Zhou P., Iadecola C., Vexler Z.S. Genetic deletion of CD36 enhances injury after acute neonatal stroke. Ann. Neurol. 2012, 72:961-970.
59. Yamanaka M., Ishikawa T., Griep A., Axt D., Kummer M.P., Heneka M.T. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J. Neurosci. 2012, 32:17321-17331.
60. Zhao X., Sun G., Zhang J., Strong R., Song W., Gonzales N., Grotta J.C., Aronowski J. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 2007, 61:352-362.